Study to Evaluate Efficacy and Safety of Pulmicort Respules in Japanese Adult Asthmatic Patients
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to show similarity of efficacy on Pulmicort Respules
1.0 mg/day or 2.0 mg/day for 6 weeks in the treatment period and the corresponding doses of
Pulmicort Turbuhaler 400 μg/day or 800 μg/day for 4 weeks in the observation period in
Japanese adult asthmatic patients with age of 16 years or older.